Luis M. Albert-Molinos

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Tumor-Infiltrating Lymphocytes as Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: Added Value of Morphological Characterization Beyond Quantification.

Tumor-Infiltrating Lymphocytes as Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: Added Value of Morphological Characterization Beyond Quantification.

Journal: Cancers

Published: May 04, 2026

First exposure to SARS-CoV-2 shapes IgG subclass switching after mRNA vaccination.

First exposure to SARS-CoV-2 shapes IgG subclass switching after mRNA vaccination.

Journal: Communications medicine

Published: February 11, 2026

Structural basis for hepatitis E virus neutralization by potent human antibodies.

Structural basis for hepatitis E virus neutralization by potent human antibodies.

Journal: Science advances

Published: May 07, 2025

Antibody and B-Cell Responses to PHH-1V81 XBB.1.16-Adapted SARS-CoV-2 Booster Vaccination Are Associated With Variant Neutralization.

Antibody and B-Cell Responses to PHH-1V81 XBB.1.16-Adapted SARS-CoV-2 Booster Vaccination Are Associated With Variant Neutralization.

Journal: Journal of medical virology

Published: April 29, 2025

Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections.

Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections.

Journal: The Journal of infection

Published: January 01, 2025

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection.

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection.

Journal: Communications medicine

Published: November 19, 2024

Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.

Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later.

Journal: The Journal of infection

Published: September 20, 2024

Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort.

Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort.

Journal: Nature communications

Published: September 18, 2024

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic.

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic.

Journal: Cell reports

Published: September 09, 2024

The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial.

The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial.

Journal: The Lancet. Infectious diseases

Published: June 26, 2024

High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination.

High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination.

Journal: Microbes and infection

Published: May 01, 2024

Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings.

Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings.

Journal: Journal of medical virology

Published: February 06, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026